Where does GE Healthcare BioProcess R&D AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), GE Healthcare BioProcess R&D AB ranks #7,412 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does GE Healthcare BioProcess R&D AB hold?

GE Healthcare BioProcess R&D AB holds 44 US utility patents granted between 2016 and 2020, spanning 16 technology areas.

What is GE Healthcare BioProcess R&D AB's Innovation Score?

GE Healthcare BioProcess R&D AB has an Innovation Score of 39.2 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does GE Healthcare BioProcess R&D AB focus on?

GE Healthcare BioProcess R&D AB's top technology area is B01D (Separation) with 36 patents, ranking #123 of 3,536 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

Is GE Healthcare BioProcess R&D AB's patent grant rate increasing or decreasing?

GE Healthcare BioProcess R&D AB's recent grant velocity is -78% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for GE Healthcare BioProcess R&D AB's patents?

GE Healthcare BioProcess R&D AB's patents average 19.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the GE Healthcare BioProcess R&D AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

GE Healthcare BioProcess R&D AB

USPTO PatentsView assignee record - 44 granted patents across 16 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01D (Separation).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, GE ranks #7,412 of 49,997 tracked US assignees by granted-patent volume, with 44 patents across 16 technology areas.

#7,412
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.2/100): 19.9
avg claims per patent: -78%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7412 · Foreign Corporation #7,412 · 44 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 44 grants
UPPER-Q #7,412/49,997
PHOTO-FINISH Femasys
CPC-FOCUS B01D · 16 areas
INNOV-THIN 39.2/100
CLAIMS-RICH 19.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -78% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Femasys Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How GE’s 39.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.1 pts (34%) Velocity 0.0 pts (0%) Breadth 14.1 pts (36%) Claim depth 11.9 pts (30%)

Qualcomm Incorporated · highest

85
Ares Trading · near

39
GE Healthcare… · this assignee

39
Han's Laser… · near

39
LiveRamp · near

39
SUN Pharma Advanced… · near

39
3D Lighting… · lowest

7

What this shows GE's Innovation Score is 39.2/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for GE?

Each dot is one of GE’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). GE’s own 19.9 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

GE vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where GE's grants concentrate

GE Healthcare BioProcess R&D AB is a focused PatentsView assignee: 16 CPC subclasses with 81.8% of grants classified under B01D (Separation). Peak complete grant year is 2019 (12 grants) versus a trough of 4 in 2016. By volume, GE sits between Femasys Inc. and Glowforge Inc..

Femasys

44
Fertin Pharma A/S

44
Fette Compacting

44
GD Midea Environm…

44
Goal Zero

44
Ganymed Pharmaceu…

44
Gemtek Technology

44
Glowforge

44
GE Healthcare Bio… ◀

44

What this shows GE holds 44 patents at rank #7,411, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near GE

By rank, the assignees closest to #7,411 in granted patent volume.

Leaders in B01D (Separation)

Other assignees with the most granted patents in GE's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for GE, neither rank-band nor same-CPC leaders (those blocks stay above). In B01D (Separation), GE ranks #123 of 3,536 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

SUN Pharma Advanced Research Company Ltd. 39 LiveRamp, Inc. 39 Ares Trading S.A. 39 Han's Laser Technology Industry Group Co., Ltd. 39

GE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

GE Healthcare BioProcess R&D AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	4	9.1%
2017	9	20.5%
2018	11	25.0%
2019	12	27.3%
2020	8	18.2%

Which technologies does GE Healthcare BioProcess R&D AB patent most?

B01D - Separation 36

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 30

C07K - Peptides 28

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 16

Y10T - Technical Subjects Covered BY Former US Classification 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

C07C - Acyclic OR Carbocyclic Compounds 2

C08B - POLYSACCHARIDES; Derivatives Thereof 2

F16L - PIPES; Joints OR Fittings FOR PIPES; Supports FOR Pipes, Cables OR Protective TUBING; Means FOR Thermal Insulation IN General 1

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 1

C12H - Pasteurisation, Sterilisation, Preservation, Purification, Clarification OR Ageing OF Alcoholic BEVERAGES; Methods FOR Altering THE Alcohol Content OF Fermented Solutions OR Alcoholic Beverages 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

GE Healthcare BioProcess R&D AB's patent record in context - here's where to go next.

GE Healthcare BioProcess R&D AB's lead technology class is B01D (Separation), 81.8% of its portfolio - see every assignee active in that class. Explore B01D
Ranked #7,412 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare GE Healthcare BioProcess R&D AB against Femasys Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.